Munafa Stock Market Course + Intraday & FNO calls 
Neurocrine Biosciences (NBIX) Technical (Analysis) Reports Neurocrine Biosciences ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Neurocrine Biosciences (NBIX)
Technical Analysis Report for NASDAQ stock NBIX Neurocrine Biosciences. Dated: 23 Oct 2026 Updated Daily. Stock trades under Health Care Deals in Biotechnology Biological Products No Diagnostic Substances in NASDAQ stock exchange
If you are looking for Tomorrow's Movement Predictions for NASDAQ stock NBIX Neurocrine Biosciences then click here. or read Experts views on Neurocrine Biosciences or Forecast & share price targets of Neurocrine Biosciences
Neurocrine Biosciences Opened at 142.74 and Closed at: 142.70, which is -0.41% of previous session's close. It moved within a range of 140.90 and 143.83
The session was a Bearish session with an average volume of 1033300, which is -20.44% of previous session's volumes.
- Even though the stock has fallen, but its short term trend is positive and in an uptrend.
- The stock has fallen, and its mid term trend is also negative and in a downtrend.
Support for tomorrow is 140.34 and resistance for tomorrow is 143.27
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 141.12, 139.55 resistance for tomorrow's hourly charts is 144.05, 145.41
10 Day SMA for Neurocrine Biosciences (NBIX) is 139.14 and stock is trading above these levels. This is a good sign for its short term trend
20 Day SMA for Neurocrine Biosciences (NBIX) is 140.64 and the stock is trading above these levels. This is a good sign for its mid term trend
50 Day SMA for Neurocrine Biosciences (NBIX) is 147.43 and the stock is trading below these levels. This is not a good sign for its mid to long term trend
100 Day SMA is 157.92 and the stock is trading below these levels. This is not a good sign for its long term trend
200 Day SMA Neurocrine Biosciences is 147.31 and stock is trading below these levels. This is not a good sign for its long term trend
20 DMA of Neurocrine Biosciences is at 140.64 and 200 DMA is at 147.31, while 50 DMA and 100 DMA are at 147.43 and 157.92 respectively
Neurocrine Biosciences (NBIX) moving average of 20 SMA is at 140.64 and 20 EMA is at 141.6
| Date | Closing Price | 20 SMA | 20 EMA |
| 23 Fri Oct | 142.70 | 140.64 | 141.6 |
| 22 Thu Oct | 143.29 | 140.42 | 141.48 |
| 21 Wed Oct | 141.31 | 140.21 | 141.29 |
| 20 Tue Oct | 142.00 | 140.11 | 141.29 |
| 19 Mon Oct | 136.98 | 140.13 | 141.21 |
| 16 Fri Oct | 135.71 | 140.48 | 141.65 |
Neurocrine Biosciences (NBIX) moving average of 50 SMA is at 147.43 and 50 EMA is at 147.01
| Date | Closing Price | 50 SMA | 50 EMA |
| 23 Fri Oct | 142.70 | 147.43 | 147.01 |
| 22 Thu Oct | 143.29 | 147.6 | 147.19 |
| 21 Wed Oct | 141.31 | 147.86 | 147.35 |
| 20 Tue Oct | 142.00 | 148.27 | 147.6 |
| 19 Mon Oct | 136.98 | 148.73 | 147.83 |
| 16 Fri Oct | 135.71 | 149.26 | 148.27 |
Neurocrine Biosciences (NBIX) moving average of 100 SMA is at 157.92 and 100 EMA is at 150.37
| Date | Closing Price | 100 SMA | 100 EMA |
| 23 Fri Oct | 142.70 | 157.92 | 150.37 |
| 22 Thu Oct | 143.29 | 158.15 | 150.53 |
| 21 Wed Oct | 141.31 | 158.26 | 150.68 |
| 20 Tue Oct | 142.00 | 158.46 | 150.87 |
| 19 Mon Oct | 136.98 | 158.62 | 151.05 |
| 16 Fri Oct | 135.71 | 158.82 | 151.33 |
Neurocrine Biosciences (NBIX) moving average of 200 SMA is at 147.31 and 200 EMA is at 147.94
| Date | Closing Price | 200 SMA | 200 EMA |
| 23 Fri Oct | 142.70 | 147.31 | 147.94 |
| 22 Thu Oct | 143.29 | 147.28 | 147.99 |
| 21 Wed Oct | 141.31 | 147.24 | 148.04 |
| 20 Tue Oct | 142.00 | 147.24 | 148.11 |
| 19 Mon Oct | 136.98 | 147.21 | 148.17 |
| 16 Fri Oct | 135.71 | 147.21 | 148.28 |
Neurocrine Biosciences has performed better than Veru Inc in short term. Holding Neurocrine Biosciences could be a better choice for now!
United Therapeutics has performed better than Neurocrine Biosciences in short term. You could have earned much better returns by investing in United Therapeutics, about 19.39% more returns!
Neurocrine Biosciences has performed better than Urogen Pharma in short term. Holding Neurocrine Biosciences could be a better choice for now!
Quidel Corporation has performed better than Neurocrine Biosciences in short term. You could have earned much better returns by investing in Quidel Corporation, about 25.17% more returns!
Neurocrine Biosciences has performed better than Omeros Corporation in short term. Holding Neurocrine Biosciences could be a better choice for now!
Neurocrine Biosciences has performed better than Nature S in short term. Holding Neurocrine Biosciences could be a better choice for now!
Neurocrine Biosciences has performed better than Aldeyra Therapeutics in short term. Holding Neurocrine Biosciences could be a better choice for now!
Neurocrine Biosciences has performed better than Arrowhead Pharmaceuticals in short term. Holding Neurocrine Biosciences could be a better choice for now!
Neurocrine Biosciences has performed better than Chemocentryx Inc in short term. Holding Neurocrine Biosciences could be a better choice for now!
Neurocrine Biosciences has performed better than Coherus Biosciences in short term. Holding Neurocrine Biosciences could be a better choice for now!
Neurocrine Biosciences has performed better than Celldex Therapeutics in short term. Holding Neurocrine Biosciences could be a better choice for now!
Neurocrine Biosciences has performed better than Cue Biopharma in short term. Holding Neurocrine Biosciences could be a better choice for now!
Neurocrine Biosciences has performed better than Delcath Systems in short term. Holding Neurocrine Biosciences could be a better choice for now!
Entera Bio has performed better than Neurocrine Biosciences in short term. You could have earned much better returns by investing in Entera Bio, about 6.94% more returns!
Neurocrine Biosciences has performed better than Evolus Inc in short term. Holding Neurocrine Biosciences could be a better choice for now!
Neurocrine Biosciences has performed better than Fulgent Genetics in short term. Holding Neurocrine Biosciences could be a better choice for now!
Hutchison China has performed better than Neurocrine Biosciences in short term. You could have earned much better returns by investing in Hutchison China, about 0.02% more returns!
Neurocrine Biosciences has performed better than Inmune Bio in short term. Holding Neurocrine Biosciences could be a better choice for now!
Neurocrine Biosciences has performed better than Mesoblast in short term. Holding Neurocrine Biosciences could be a better choice for now!
Neurocrine Biosciences Technical analysis of indicators
Price action analysis of Neurocrine Biosciences (NBIX) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
ADX buy sell signal for Neurocrine Biosciences stock for short term is BUY. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Neurocrine Biosciences in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Neurocrine Biosciences Stock is trading near its recent HIGHS, which reflects strong buying momentum in short term! Bulls are getting stronger in this stock.
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Neurocrine Biosciences in short term but SELL signal is weak.
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Neurocrine Biosciences is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 138.84 and Neurocrine Biosciences NBIX stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Neurocrine Biosciences NBIX stock. Volume based technical analysis of Neurocrine Biosciences NBIX stock is negative.
Neurocrine Biosciences Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for NASDAQ stock NBIX Neurocrine Biosciences These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And NBIX Experts View which covers a lot of information including buying and selling signals
NBIX future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Neurocrine Biosciences or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Neurocrine Biosciences (NBIX) Technical (Analysis) Reports Neurocrine Biosciences ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Hindi Basics How To Trade In FnO Futures Options Stock Market
Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You
- NASDAQ Screeners
- NASDAQ Daily Screener
- NASDAQ Weekly Screener
- NASDAQ Monthly Screener
- Support & Resistance
- NASDAQ Shares Near Support
- NASDAQ Shares Near Resistance
